Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGC| |ATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGG
End
84188048/83960924 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/4094341; hsa-mir-10b/Downstream/1822676;
Upstream sequence
GGTATATATGGAAAGAGCTTtttttttagctttttttttttttttttttttttgagacggagtctcgctctgccgcccaggctggattgcagtggcacca
Downstream sequence
tcgctgttcactgcaacctctgcctcccgggttcaagcgattcccctgcctcagcctctctagtagccacgacgcccagctaattttttgtatttttagt
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.